Efficacy of ixekizumab treatment, K.A. Papp et al

preview_player
Показать описание
Author video for 'Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)'

  1. British Journal of Dermatology
Рекомендации по теме
Efficacy of ixekizumab 0:01:43

Efficacy of ixekizumab treatment, K.A. Papp et al

Ixekizumab efficacy and 0:04:03

Ixekizumab efficacy and safety in moderate-to-severe genital psoriasis, C. Ryan et al.

Ixekizumab for the 0:06:34

Ixekizumab for the treatment of biologic-naive patients with active psoriatic arthritis

Ixekizumab vs. guselkumab 0:04:08

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

Long-term efficacy and 0:02:54

Long-term efficacy and safety of tildrakizumab, K. Reich et al

Taltz (ixekizumab): Uses, 0:01:24

Taltz (ixekizumab): Uses, How It Works, and Common Side Effects | Drugs.com

Ixekizumab is safe 0:03:49

Ixekizumab is safe and effective for the treatment of moderate to severe plaque psoriasis

AxSpA Podcast: The 0:25:41

AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab

Ixekizumab for the 0:05:40

Ixekizumab for the treatment of psoriasis

Network meta-analysis comparing 0:00:46

Network meta-analysis comparing the efficacy of biologic treatments for achieving com... | RTCL.TV

Ken Gordon, MD: 0:02:22

Ken Gordon, MD: Insights on Risankizumab for Plaque Psoriasis

Ixekizumab vs. guselkumab 0:05:17

Ixekizumab vs. guselkumab in plaque psoriasis, Blauvelt et al

25th EADV Congress. 0:06:24

25th EADV Congress. Late-breaking insight: Ixekizumab vs. ustekinumab head-to-head data in psoriasis

Efficacy and Safety 0:06:03

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

Brodalumab in patients 0:03:03

Brodalumab in patients with GPP and PsE, K. Yamasaki et al

Study shows early 0:01:01

Study shows early response to biologics linked to stable long term efficacy in psoriasis

Eli Lilly's New 0:04:11

Eli Lilly's New Drug Taltz

IL-23 Inhibitors and 0:24:02

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

IL-17 Inhibitors 0:25:20

IL-17 Inhibitors

IXORA-S study: ixekizumab 0:03:02

IXORA-S study: ixekizumab vs. ustekinumab at week 24, K. Reich et al

PsA Podcast: Guselkumab 0:26:48

PsA Podcast: Guselkumab & Secukinumab – All the Latest in Efficacy & Safety

Tildrakizumab long-term effectiveness 0:02:30

Tildrakizumab long-term effectiveness

Tralokinumab monotherapy in 0:05:21

Tralokinumab monotherapy in atopic dermatitis: phase III results, A. Wollenberg et al

Jeffrey Weinberg, MD: 0:01:59

Jeffrey Weinberg, MD: Psoriasis Duration Doesn’t Impact Brodalumab Success

join shbcf.ru